Company intelligence

ASTH

Astrana Health, Inc. · NASDAQ · Healthcare

Price$37.99+1.01% · +$0.38

Market cap1.88BEquity value

P / E45.8Trailing ratio

Volume9.27KLatest session

Market data

ASTH price chart

TradingView

Related signals

1 min delayed

Browse public ASTH signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ASTHJan 28, 2026+3.77% since signal

Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst

ASTH's stock plummeted 22% following CMS's proposed Medicare payment updates for 2027, indicating minimal growth for Medicare Advantage. The company's reliance on Medicare shines a spotlight on its revenue structure, but some analysts view the current price drop as a potential buying opportunity given long-term growth prospects in delegated care agreements.

View signal analysis

ASTHJul 11, 2024+5.88% since signal

Analyst Sees Pent-Up Demand Impact On Astrana Health's Value-Based Care Model

Truist Securities upgraded Astrana Health Inc ASTH. Astrana serves over 10,000 providers and 1.0 million patients. Lower trends compared to peers indicate potential pent-up demand captured by Astrana's care model. Truist sees underappreciated tailwinds for Astrana, including presence in Southern California and low RAF score advantage. Astrana Health projected revenue growth of 25%-30% in the next few years.

View signal analysis

Research